Summary
Cells are constantly challenged by complex crosslinking damage, which is caused not only by endogenous metabolites, such as reactive aldehydes, but also by various exogenous sources. While crosslinking damage to DNA has been studied extensively, almost all reactive agents act pleiotropically and also damage RNA and proteins. However, due to the complexity of the damage, it is difficult to determine which components of the damage are responsible for specific cellular outcomes. Therefore, it is unknown how crosslinking damage to RNA and proteins affects cellular homeostasis and how it is detected and resolved.
Here, I propose to exploit novel experimental model systems that deconstruct complex crosslinking damage into distinct toxic components. I will combine metabolic labelling with photoactivatable-crosslinking approaches to mimic aldehyde-induced RNA or protein damage in the absence of DNA damage. We will combine these model systems with genetic and proteomic approaches to define the molecular mechanisms that detect and resolve RNA-protein crosslinks and protein-protein crosslinks. To this end, we will capitalize on preliminary work indicating the existence of an entirely uncharacterized translation-coupled quality control mechanism that ubiquitylates and degrades proteins crosslinked to mRNA. Ultimately, I will build on these mechanistic insights to explore the physiological role of RNA and protein damage in (1) the response to endogenous formaldehyde generated during cellular differentiation and (2) the mechanisms-of-action of chemotherapeutic crosslinkers.
My work will provide a comprehensive view on how complex crosslinking damage affects cellular homeostasis and will challenge the current paradigm that DNA damage is solely responsible for the cytotoxicity of crosslinking agents. As such, my work will address a major blind spot in the fields of cellular quality control and genome stability with wide-ranging implications for cancer therapy and ageing.
Here, I propose to exploit novel experimental model systems that deconstruct complex crosslinking damage into distinct toxic components. I will combine metabolic labelling with photoactivatable-crosslinking approaches to mimic aldehyde-induced RNA or protein damage in the absence of DNA damage. We will combine these model systems with genetic and proteomic approaches to define the molecular mechanisms that detect and resolve RNA-protein crosslinks and protein-protein crosslinks. To this end, we will capitalize on preliminary work indicating the existence of an entirely uncharacterized translation-coupled quality control mechanism that ubiquitylates and degrades proteins crosslinked to mRNA. Ultimately, I will build on these mechanistic insights to explore the physiological role of RNA and protein damage in (1) the response to endogenous formaldehyde generated during cellular differentiation and (2) the mechanisms-of-action of chemotherapeutic crosslinkers.
My work will provide a comprehensive view on how complex crosslinking damage affects cellular homeostasis and will challenge the current paradigm that DNA damage is solely responsible for the cytotoxicity of crosslinking agents. As such, my work will address a major blind spot in the fields of cellular quality control and genome stability with wide-ranging implications for cancer therapy and ageing.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/101124695 |
| Start date: | 01-05-2024 |
| End date: | 30-04-2029 |
| Total budget - Public funding: | 2 000 000,00 Euro - 2 000 000,00 Euro |
Cordis data
Original description
Cells are constantly challenged by complex crosslinking damage, which is caused not only by endogenous metabolites, such as reactive aldehydes, but also by various exogenous sources. While crosslinking damage to DNA has been studied extensively, almost all reactive agents act pleiotropically and also damage RNA and proteins. However, due to the complexity of the damage, it is difficult to determine which components of the damage are responsible for specific cellular outcomes. Therefore, it is unknown how crosslinking damage to RNA and proteins affects cellular homeostasis and how it is detected and resolved.Here, I propose to exploit novel experimental model systems that deconstruct complex crosslinking damage into distinct toxic components. I will combine metabolic labelling with photoactivatable-crosslinking approaches to mimic aldehyde-induced RNA or protein damage in the absence of DNA damage. We will combine these model systems with genetic and proteomic approaches to define the molecular mechanisms that detect and resolve RNA-protein crosslinks and protein-protein crosslinks. To this end, we will capitalize on preliminary work indicating the existence of an entirely uncharacterized translation-coupled quality control mechanism that ubiquitylates and degrades proteins crosslinked to mRNA. Ultimately, I will build on these mechanistic insights to explore the physiological role of RNA and protein damage in (1) the response to endogenous formaldehyde generated during cellular differentiation and (2) the mechanisms-of-action of chemotherapeutic crosslinkers.
My work will provide a comprehensive view on how complex crosslinking damage affects cellular homeostasis and will challenge the current paradigm that DNA damage is solely responsible for the cytotoxicity of crosslinking agents. As such, my work will address a major blind spot in the fields of cellular quality control and genome stability with wide-ranging implications for cancer therapy and ageing.
Status
SIGNEDCall topic
ERC-2023-COGUpdate Date
12-03-2024
Images
No images available.
Geographical location(s)
